Cancer

RSS

Testing reveals lurtotecan is less active than its low-clearance formulation

Aug. 30, 2000

Vion begins additional phase I trial of intravenous TAPET

Aug. 29, 2000

Research points to existence of a third hereditary breast cancer gene

Aug. 29, 2000

Inex broadens Onco TCS clinical trial program

Aug. 28, 2000

New testosterone derivatives patented by Schering AG

Aug. 28, 2000

Phase I trial of novel anticancer treatment under way

Aug. 28, 2000

Synthetic analogues of 1alpha,25-(OH)2D3 may be useful in cancer chemoprevention

Aug. 28, 2000

Roche reports synthesis and antitumor activity of Ro-27-0574

Aug. 28, 2000

Vanadocenes induce germ cell apoptosis in mouse model of testicular cancer

Aug. 28, 2000

Selenazolidine prodrugs synthesized as potential chemopreventive agents

Aug. 25, 2000